JP2023511376A5 - - Google Patents

Info

Publication number
JP2023511376A5
JP2023511376A5 JP2022544309A JP2022544309A JP2023511376A5 JP 2023511376 A5 JP2023511376 A5 JP 2023511376A5 JP 2022544309 A JP2022544309 A JP 2022544309A JP 2022544309 A JP2022544309 A JP 2022544309A JP 2023511376 A5 JP2023511376 A5 JP 2023511376A5
Authority
JP
Japan
Application number
JP2022544309A
Other languages
Japanese (ja)
Other versions
JP7710450B2 (ja
JP2023511376A (ja
JPWO2021148006A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2021/073347 external-priority patent/WO2021148006A1/en
Publication of JP2023511376A publication Critical patent/JP2023511376A/ja
Publication of JP2023511376A5 publication Critical patent/JP2023511376A5/ja
Publication of JPWO2021148006A5 publication Critical patent/JPWO2021148006A5/ja
Priority to JP2025114854A priority Critical patent/JP2025160226A/ja
Application granted granted Critical
Publication of JP7710450B2 publication Critical patent/JP7710450B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022544309A 2020-01-23 2021-01-22 Fc変異を有するヘテロダイマータンパク質 Active JP7710450B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025114854A JP2025160226A (ja) 2020-01-23 2025-07-08 Fc変異を有するヘテロダイマータンパク質

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2020/073960 2020-01-23
CN2020073960 2020-01-23
PCT/CN2021/073347 WO2021148006A1 (en) 2020-01-23 2021-01-22 Heterodimeric proteins with fc mutations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025114854A Division JP2025160226A (ja) 2020-01-23 2025-07-08 Fc変異を有するヘテロダイマータンパク質

Publications (4)

Publication Number Publication Date
JP2023511376A JP2023511376A (ja) 2023-03-17
JP2023511376A5 true JP2023511376A5 (https=) 2025-04-21
JPWO2021148006A5 JPWO2021148006A5 (https=) 2025-04-21
JP7710450B2 JP7710450B2 (ja) 2025-07-18

Family

ID=76992067

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022544309A Active JP7710450B2 (ja) 2020-01-23 2021-01-22 Fc変異を有するヘテロダイマータンパク質
JP2025114854A Pending JP2025160226A (ja) 2020-01-23 2025-07-08 Fc変異を有するヘテロダイマータンパク質

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025114854A Pending JP2025160226A (ja) 2020-01-23 2025-07-08 Fc変異を有するヘテロダイマータンパク質

Country Status (11)

Country Link
US (1) US20230124669A1 (https=)
EP (1) EP4093778A4 (https=)
JP (2) JP7710450B2 (https=)
KR (1) KR20220145833A (https=)
CN (1) CN115279796A (https=)
AU (1) AU2021210482A1 (https=)
BR (1) BR112022014574A2 (https=)
CA (1) CA3165045A1 (https=)
IL (1) IL294878A (https=)
MX (1) MX2022009101A (https=)
WO (1) WO2021148006A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022170619A1 (en) * 2021-02-11 2022-08-18 Adagene Pte. Ltd. Anti-cd3 antibodies and methods of use thereof
EP4405398A4 (en) * 2021-09-21 2025-10-29 Qilu Puget Sound Biotherapeutics Corp FC HETERODIMERS ALLOWING THE MANUFACTURE OF FUSION PROTEINS AND BI-SPECIFIC ANTIBODIES
WO2023183888A1 (en) * 2022-03-23 2023-09-28 Cytomx Therapeutics, Inc. Activatable antigen-binding protein constructs and uses of the same
WO2023193239A1 (en) 2022-04-08 2023-10-12 Peter Peizhi Luo Anti-cd28 antibodies and methods of use thereof
AU2024287529A1 (en) * 2023-07-10 2026-02-05 Regeneron Pharmaceuticals, Inc. Bispecific pd-l1x4-1bb antibodies and methods of use thereof
WO2025108310A1 (zh) * 2023-11-20 2025-05-30 江苏恒瑞医药股份有限公司 通过重组反应制备异源多聚体的方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101270829B1 (ko) * 2004-09-23 2013-06-07 제넨테크, 인크. 시스테인 유전자조작 항체 및 접합체
US8054928B2 (en) * 2005-11-14 2011-11-08 Ati Technologies, Inc. Programmable preamble system and method
US20100189651A1 (en) * 2009-01-12 2010-07-29 Cytomx Therapeutics, Llc Modified antibody compositions, methods of making and using thereof
US9493578B2 (en) * 2009-09-02 2016-11-15 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
CN102958942A (zh) * 2009-12-29 2013-03-06 新兴产品开发西雅图有限公司 异二聚体结合蛋白及其应用
CN114805583A (zh) * 2010-05-27 2022-07-29 根马布股份公司 针对her2的单克隆抗体
US10344050B2 (en) * 2011-10-27 2019-07-09 Genmab A/S Production of heterodimeric proteins
WO2013118722A1 (ja) * 2012-02-06 2013-08-15 トヨタ自動車株式会社 硫化物固体電解質材料、電池および硫化物固体電解質材料の製造方法
UY35148A (es) * 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
CA2902739C (en) * 2013-03-15 2022-11-22 Xencor, Inc. Heterodimeric proteins
CN110627907B (zh) * 2013-11-04 2024-03-29 艾科诺斯科技股份有限公司 重靶向t细胞的异源二聚免疫球蛋白的产生
US20160176969A1 (en) * 2014-11-26 2016-06-23 Xencor, Inc. Heterodimeric antibodies including binding to cd8
CN107001482B (zh) * 2014-12-03 2021-06-15 豪夫迈·罗氏有限公司 多特异性抗体
WO2016152136A1 (ja) * 2015-03-20 2016-09-29 日本電気株式会社 プラガブル光モジュール、光通信システム及びプラガブル光モジュールの制御方法
CN106883297B (zh) * 2015-12-16 2019-12-13 苏州康宁杰瑞生物科技有限公司 基于ch3结构域的异二聚体分子、其制备方法及用途
EP3489262A4 (en) * 2016-07-19 2020-07-08 Ibentrus, Inc. BISPECIFIC PROTEINS AND PROCESSES FOR THEIR PREPARATION
WO2019014912A1 (zh) * 2017-07-21 2019-01-24 赵磊 一种异二聚体蛋白及其制备方法
EP3728326A4 (en) * 2017-12-21 2021-12-15 Amunix Pharmaceuticals, Inc. SEPARATING SEGMENTS AND BINDING COMPOSITIONS THEREFORE
WO2019148445A1 (en) * 2018-02-02 2019-08-08 Adagene Inc. Precision/context-dependent activatable antibodies, and methods of making and using the same
TWI798601B (zh) * 2020-11-27 2023-04-11 晶睿通訊股份有限公司 地面起伏偵測方法及其監控攝影機
JP7295438B2 (ja) * 2020-11-30 2023-06-21 日亜化学工業株式会社 面状光源
WO2023193239A1 (en) * 2022-04-08 2023-10-12 Peter Peizhi Luo Anti-cd28 antibodies and methods of use thereof

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2023511376A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)
BR102021016375A2 (https=)
BR102021012003A2 (https=)
BR102021012107A2 (https=)